{* traditionalSignIn_emailAddress *}


The prescription versions are used to reduce stomach acid to prevent and treat conditions, such as heartburn, ulcers of the stomach and intestines and gastroesophageal reflux disease (GERD), Health Canada said.Ranitidine works by blocking the action of acid-producing cells in the stomach. Health Canada said on Wednesday four more companies were recalling heartburn drug ranitidine, commonly known by its brand name Zantac, after presence of a probable cancer-causing impurity was found in some of the drugs. Product: Over-the-counter and prescription ranitidine drugs. Due to inconsistencies in preliminary test results of the key ingredient used in the U.S. and Canadian products, Sanofi decided to carry out the recall in those countries as an investigation continues. {* #tradAuthenticateMergeForm *} "There were some impurities found in the manufacturing plant that is used to manufacture the prescription strengths of Zantac and ranitidine. and European Union health officials are investigating levels of the probable carcinogen NDMA in Zantac and its generic equivalent sold by numerous other companies. Please note that CBC does not endorse the opinions expressed in comments. They could use calcium antacids" for mild symptoms, McDonald said in an email.

The federal agency said consumers could consider taking another heartburn medicine or contact their doctor.Health Canada also said it was investigating the possible presence of a carcinogen in some ranitidine drugs available by prescription and over-the-counter. As a result, and at Health Canada’s request, companies marketing ranitidine products in Canada …

Last week, Health Canada said it is assessing the issue of an impurity called N-nitrosodimethylamine (NDMA) detected in some ranitidine drugs.
UPDATE: October 18, 2019 - Additional ranitidine products recalled, including Zantac; … Issue: Health Canada is providing an update on the status of ranitidine drugs in Canada, including enhanced safety measures the Department is putting in … Evaluations of the product are on-going however, due to inconsistencies in preliminary test results of the active ingredient used in Zantac, Sanofi has, as a precautionary measure, made the decision to conduct a voluntary recall of Zantac in Canada … Drug Recall Subcategory: Drugs Hazard classification: Type I Source of recall: Health Canada Issue: Product Safety Audience: General Public, Healthcare Professionals, Hospitals Identification number: RA-71031.

The FDA said its lower temperature testing method has shown lower levels.Last year, NDMA was found in some blood pressure medicines from a class of drugs known as angiotensin II receptor blockers, or ARBs, which also led to recalls. Due to inconsistencies in preliminary test results of … {* #userInformationForm *}

The FDA has advised patients that there are other medications available to treat the same symptoms that ranitidine is intended to soothe.Branded Zantac is made by Sanofi, while generic versions are manufactured by many companies. In addition, manufacturers have recalled some generic versions of Zantac products known as ranitidine. Last updated: 2019-09-18. In order to comply with Health Canada's guidance, as a precautionary measure, Sanofi in Canada is holding all distribution of Zantac until further notice – no further action is required for product currently on the market," Sanofi Canada spokesperson Christine Homsy said Wednesday.NDMA is classified as a probable human carcinogen, meaning long-term exposure to levels above what is considered safe could increase the risk of cancer. Four companies, Apotex Inc., Pro Doc Ltée, Sanis Health Inc. and Sivem Pharmaceuticals, are recalling ranitidine drugs.

Heartburn drug Zantac recalled in Canada, U.S. over contamination fears The following is a timeline on Zantac: 1983 Glaxo Holdings Ltd, now a part … 9 Easy Heartburn Remedies to Get You Back to NormalAntacids vs. H2 Blockers vs. Proton Pump Inhibitors (PPIs)We know there’s been a lot of recent news about Zantac. Comments on this story are moderated according to ourIt is a priority for CBC to create a website that is accessible to all Canadians including people with visual, hearing, motor and cognitive challenges.Closed Captioning and Described Video is available for many CBC shows offered onGlaxoSmithKline is recalling the prescription version of heartburn medicine Zantac in all markets as a precaution. Drugmaker Sanofi is recalling its over-the-counter heartburn drug Zantac in the U.S. and Canada because of possible contamination.The French company Friday joined other drugmakers that have recently recalled their versions of the popular heartburn and ulcer drug.In September, the U.S. Food and Drug Administration said a potentially cancer-causing chemical had been detected at low levels in prescription and over-the-counter versions of Zantac. "Sanofi in Canada has not recalled Zantac, a lower dose, over-the-counter ranitidine medication. {* forgotPassword_sendButton *} Product: A. Sandoz Ranitidine 150 mg Tablet B. Sandoz Ranitidine 300 mg Tablet Reason Depth of distribution Affected products A.



Canadian consumers who grab Zantac and other medications containing ranitidine off the pharmacy shelf can continue to do so despite a global recall of the prescribed version.In Canada, Sanofi is the only manufacturer of branded Zantac, and it's only available over-the-counter, the company said.